These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 30277861
1. Simultaneous inhibition of c-Abl and Src kinases abrogates the exaggerated expression of profibrotic genes in cultured systemic sclerosis dermal fibroblasts. Piera-Velazquez S, Jimenez SA. Clin Exp Rheumatol; 2018; 36 Suppl 113(4):36-44. PubMed ID: 30277861 [Abstract] [Full Text] [Related]
2. Abrogation of transforming growth factor-β-induced tissue fibrosis in TBRIcaCol1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib). Wermuth PJ, Jimenez SA. PLoS One; 2018; 13(5):e0196559. PubMed ID: 29718973 [Abstract] [Full Text] [Related]
6. Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts. Cutolo M, Ruaro B, Montagna P, Brizzolara R, Stratta E, Trombetta AC, Scabini S, Tavilla PP, Parodi A, Corallo C, Giordano N, Paolino S, Pizzorni C, Sulli A, Smith V, Soldano S. Arthritis Res Ther; 2018 May 02; 20(1):77. PubMed ID: 29720235 [Abstract] [Full Text] [Related]
11. Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis. Skhirtladze C, Distler O, Dees C, Akhmetshina A, Busch N, Venalis P, Zwerina J, Spriewald B, Pileckyte M, Schett G, Distler JH. Arthritis Rheum; 2008 May 02; 58(5):1475-84. PubMed ID: 18438865 [Abstract] [Full Text] [Related]
12. c-Abl silencing reduced the inhibitory effects of TGF-β1 on apoptosis in systemic sclerosis dermal fibroblasts. Karimizadeh E, Gharibdoost F, Motamed N, Jafarinejad-Farsangi S, Jamshidi A, Mahmoudi M. Mol Cell Biochem; 2015 Jul 02; 405(1-2):169-76. PubMed ID: 25876876 [Abstract] [Full Text] [Related]